Abstract:Cell death is attributed to the unrecoverable disturbance of cells exposed to intracellular or extracellular stimulus. Regulated cell death (RCD), also known as programmed cell death (PCD), involves signaling cascades in which effector molecules participate in and play important roles for maintaining organism homeostasis. As a basic biological phenomenon of cells, RCD displays exceptional influence on the occurrence and development of many pathophysiological processes. N6-methyladenosine (m6A) is an important epigenetic modification that regulates RNA fate and subsequent bioprocesses. It occurs extensively on multiple RNA species and is the most abundant internal modification of eukaryotic messenger RNA (mRNA). The abundance of m6A modification is regulated by its methyltransferases and demethylases, and the diverse biological functions of m6A are executed by distinct m6A binding proteins. Accruing evidence shows that m6A modification participates in eukaryotic cell fate transition and determination. In recent years, the disorder of m6A modification status has been observed during the initiation and progression of various RCDs, including classical apoptosis, necroptosis, pyroptosis, and the newly described ferroptosis. Due to the importance of m6A and RCD in cellular and organismal homeostasis, it is worthwhile to recapitulate and organize the current knowledge of the crosstalk between m6A status and RCDs with distinct biochemical and morphological features, as well as immune consequences. In this chapter, we systematically summarize the regulatory networks of m6A modification on RCDs to provide the profiling of m6A-RCD regulatory axis as comprehensively as possible.

The role of N6-methyladenosine (m6A) modification in the regulation of circRNAs

Novel insights into the interaction between N6-methyladenosine modification and circular RNA

N6-Methyladenosine Modification Opens a New Chapter in Circular RNA Biology

Rna N-6-Methyladenosine Methylation In Post-Transcriptional Gene Expression Regulation

The emerging roles of N6-methyladenosine RNA methylation in human cancers

Overview of m6A and circRNAs in human cancers

The Roles of M6a RNA Modifiers in Human Cancer

The roles of m<SUP>6</SUP>A RNA modifiers in human cancer

N6-methyladenosine modifications: interactions with novel RNA-binding proteins and roles in signal transduction.

Advances in detecting N6-methyladenosine modification in circRNAs

The role of m6A modification in the biological functions and diseases

Multifaceted Functions of RNA m6A Modification in Modulating Regulated Cell Death

Cross-talk between circRNAs and m6A modifications in solid tumors

Role of N6-methyladenosine RNA modification in cancer

The role of m6A modification in physiology and disease

RNA N6-Methyladenine Modification, Cellular Reprogramming, and Cancer Stemness

Role of N6-Methyladenosine RNA Modification in Cardiovascular Disease

RNA M6a Modification in Cancers: Molecular Mechanisms and Potential Clinical Applications.

Regulation of m6Am RNA modification and its implications in human diseases

The biogenesis, biological functions and modification of Circular RNAs

The Roles of N6-methyladenosine and Its Target Regulatory Noncoding RNAs in Tumors: Classification, Mechanisms, and Potential Therapeutic Implications.